(Date:12/1/2009)..., WASHINGTON, Dec. 1 ...soners and 1,538 federal prisoners were HIV positi...atistics (BJS) in the Office of Justice Programs, ...arend 2008, an estimated 5,672 inmates in state an...762 in 2007. In 2007, about 43 per 10,000 prison i...
(Date:12/1/2009)...fy those who would benefit from liver surgery afte... 1 (HealthDay News) -- A CT scan of liver tumors c...predict overall survival after chemotherapy, resea...o cytotoxic chemotherapy has been shown to improve...ancer and to produce better results in patients ha...
(Date:12/1/2009)... Practitioners of any medical, legal ...are breathing a sigh of relief this week with the ... application, released over the holiday weekend, a...ice recordings to do so quickly and seamlessly usi... (PRWEB) December 1, 2009 -- The iPhone App,...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNewswire/ ...l leader in the development and delivery of custom...ical, scientific and academic markets, will be sho...ch, our first-to-market cross-platform search solu...exicon, based on the American Psychological Associ...
(Date:12/1/2009)..., FORT LAUDERDALE, Fla., Dec. 1 Or... enrollment in the randomized clinical trial of th...mbo Stent). ,, A prospective, randomized, multi...on of an ablu M inal sirolimus coat ED bio- ...t up to 20 sites in Asia, Australia, Europe and So...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4